Aldactone is a brand of spironolactone, a potassium-sparing diuretic that helps the body shed excess fluid while retaining potassium. It’s prescribed for heart failure, resistant hypertension, edema from liver or kidney disease, and primary hyperaldosteronism. Many clinicians also use spironolactone off-label for acne, hirsutism, and PCOS due to its anti-androgen effects. Because it can affect electrolytes and kidney function, Aldactone requires medical oversight, lab monitoring, and individualized dosing. This guide explains common uses, dosing, precautions, side effects, interactions, and how to access Aldactone safely and legally in the United States.
Aldactone (spironolactone) is a potassium-sparing diuretic and aldosterone antagonist. By blocking aldosterone’s effects in the kidneys and other tissues, it helps remove excess sodium and water without depleting potassium. Clinically, it is used to reduce morbidity and mortality in heart failure with reduced ejection fraction, to treat resistant hypertension, and to manage edema associated with cirrhosis and nephrotic syndrome. It is also used to diagnose and treat primary hyperaldosteronism (Conn’s syndrome).
Off-label, spironolactone is frequently prescribed for hormonal acne, hirsutism, and symptoms related to polycystic ovary syndrome due to its anti-androgen properties. Some gender-affirming care protocols include spironolactone to reduce androgen effects. All uses should be supervised by a clinician, with periodic monitoring of kidney function and electrolytes to mitigate risks like hyperkalemia.
Dosing is individualized based on the condition, kidney function, and response. For heart failure, clinicians often start at 12.5–25 mg once daily and titrate to 25–50 mg daily if tolerated, guided by potassium and creatinine. In resistant hypertension, typical doses range from 25–50 mg once daily, occasionally up to 100 mg/day in divided doses. For edema due to cirrhosis or nephrotic syndrome, 25–200 mg/day may be used, often combined with a loop diuretic, with careful sodium restriction and monitoring.
For primary hyperaldosteronism, dosing varies widely (often 100–400 mg/day) depending on whether it is used diagnostically, preoperatively, or as long-term therapy when surgery is not an option. Off-label for acne or hirsutism, clinicians commonly start at 25–50 mg/day and titrate to 100–200 mg/day based on response and tolerability. Because spironolactone can raise potassium, baseline and follow-up labs are essential, especially after initiation and dose increases.
Take Aldactone at the same time each day with food to minimize stomach upset. If a diuretic effect disrupts sleep, morning dosing is often preferred. Do not adjust your dose or add potassium supplements or salt substitutes containing potassium without medical advice.
Aldactone can increase serum potassium and affect kidney function. Before starting and periodically during therapy, your clinician will check electrolytes and renal function. Hyperkalemia risk is higher in older adults, those with chronic kidney disease, diabetes, or when used with ACE inhibitors, ARBs, aliskiren, or potassium supplements. Report symptoms like muscle weakness, palpitations, or profound fatigue promptly.
Spironolactone has anti-androgen effects that may cause menstrual irregularities, breast tenderness, or decreased libido. Dizziness or low blood pressure can occur, particularly when combined with other antihypertensives, after alcohol, or during dehydration. In patients with advanced liver disease, cautious titration and close monitoring are vital to avoid electrolyte shifts that may precipitate encephalopathy.
The product carries a tumorigenicity warning based on high-dose animal data; use only for approved or well-justified indications. Discuss pregnancy plans: spironolactone is generally avoided during pregnancy due to potential effects on a male fetus. In breastfeeding, limited data suggest low risk, but individualized risk–benefit discussions are advised.
Do not use Aldactone if you have hyperkalemia, anuria, acute renal insufficiency, Addison’s disease, or a known hypersensitivity to spironolactone. Avoid combining with other potassium-sparing diuretics (such as amiloride or triamterene). Use with extreme caution—or avoid—in severe kidney impairment unless guided by a specialist. Spironolactone is typically avoided in pregnancy for non–life-threatening indications. Always review your full medication list and medical history with your clinician before starting.
Common side effects include increased urination, dizziness, low blood pressure, gastrointestinal upset (nausea, diarrhea), headache, and fatigue. Due to anti-androgen activity, some people experience breast tenderness, gynecomastia (in men), menstrual irregularities, or changes in libido. Acne patients may notice increased urination and initial breast tenderness that often settles with time and dose adjustment.
Serious adverse effects include hyperkalemia, hyponatremia, kidney dysfunction, and rare hypersensitivity reactions (rash, angioedema). Signs of dangerous potassium elevation include muscle weakness, tingling, flaccid paralysis, or heart rhythm changes (palpitations, syncope). Seek urgent care if you develop severe lightheadedness, fainting, chest pain, or signs of an allergic reaction. Periodic lab monitoring helps detect problems early so dosing can be adjusted or therapy discontinued.
Drugs that raise potassium or reduce kidney perfusion increase the risk of hyperkalemia with Aldactone. Notable interactions include ACE inhibitors (such as lisinopril), ARBs (such as losartan), aliskiren, potassium supplements, potassium-containing salt substitutes, trimethoprim (including TMP-SMX), and heparin/low–molecular weight heparins. Nonsteroidal anti-inflammatory drugs (NSAIDs) can blunt diuretic effect and worsen kidney function when combined.
Spironolactone can increase digoxin levels; monitor for toxicity if used together. Diuretics may increase lithium levels and toxicity risk; avoid or monitor closely. Alcohol and other blood pressure–lowering agents may enhance hypotensive effects. While hepatic metabolism occurs, cytochrome-mediated interactions are generally less prominent than with many other drugs; nonetheless, always provide your pharmacist and clinician with a complete medication and supplement list, including herbal products like licorice (which can counteract aldosterone blockade) and high-dose DHEA or testosterone products (which may affect androgen-related outcomes).
If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. If it is near your next dose, skip the missed dose and resume your regular schedule. Do not double up to “catch up.” If you miss doses frequently, set reminders and discuss adherence strategies with your clinician.
Overdose may cause drowsiness, dizziness, nausea, vomiting, diarrhea, dehydration, low blood pressure, and dangerous electrolyte disturbances—especially hyperkalemia—which can trigger life-threatening arrhythmias. Seek emergency care immediately or contact Poison Control at 1-800-222-1222 in the U.S. Management typically includes cardiac monitoring, serial electrolytes, IV fluids, and targeted therapies to correct potassium and sodium abnormalities. Bring the medication bottle or a list of doses taken to assist clinicians.
Store Aldactone at room temperature (68–77°F or 20–25°C) in a dry place, away from excess heat and light. Keep tablets in their original container with the lid tightly closed and out of reach of children and pets. Do not store in the bathroom. Dispose of unused or expired medication through a take-back program; do not flush unless instructed.
In the United States, Aldactone (spironolactone) is a prescription-only medicine. It is not legal or safe to buy Aldactone without a prescription, and websites offering “no-Rx” sales often dispense counterfeit or substandard drugs and bypass critical safety checks like kidney function and potassium monitoring. The responsible path is to obtain a clinician’s evaluation—often achievable conveniently through telehealth—and fill the prescription at a licensed pharmacy (local or mail order).
If you are seeking a streamlined experience without an in-person office visit, many reputable health systems and telemedicine services provide same- or next-day online consultations. After a licensed clinician confirms that Aldactone is appropriate, they will issue a prescription that can be sent electronically to your pharmacy. Ask about generics (spironolactone), price matching, discount programs, or manufacturer and nonprofit assistance options. Bottom line: while queries about how to “buy Aldactone without prescription” are common, U.S. law requires a valid prescription; legitimate providers can make the process fast, legal, and safe with proper monitoring to protect your heart, kidneys, and electrolytes.
Aldactone is the brand name for spironolactone, a potassium-sparing diuretic and mineralocorticoid receptor antagonist used to treat conditions driven by excess aldosterone, fluid retention, and certain hormone-related issues.
It blocks aldosterone at the mineralocorticoid receptor, causing the kidneys to excrete sodium and water while retaining potassium, reducing edema, lowering blood pressure, and blunting harmful aldosterone effects on the heart and blood vessels.
It’s prescribed for heart failure, resistant hypertension, edema from cirrhosis or nephrotic syndrome, primary hyperaldosteronism, and off-label for acne, hirsutism, and symptoms of PCOS in appropriate patients.
Avoid if you have high potassium (hyperkalemia), Addison’s disease, anuria or acute severe kidney failure, or a known allergy to spironolactone. Use caution in chronic kidney disease, with ACE inhibitors/ARBs, or potassium supplements; discuss with your clinician.
Dizziness, breast tenderness, menstrual changes, spotting, decreased libido, mild nausea, and increased urination are common. In men, gynecomastia (breast enlargement) can occur. Many effects improve as your body adjusts.
Hyperkalemia is the key risk—symptoms include muscle weakness, tingling, irregular heartbeat, or palpitations. Severe dehydration, low blood pressure, and kidney function decline can occur. Very rarely, severe skin reactions. Seek urgent care for warning signs.
For swelling, you may notice diuresis within hours and reduced edema in 2–3 days. Blood pressure improvements typically appear within 2–4 weeks. For acne or hirsutism, allow 8–12 weeks for visible results.
Take at the same time daily, with food if it upsets your stomach. Avoid high-potassium salt substitutes unless your clinician approves. Do not double up if you miss a dose; take the next dose as scheduled.
Yes. Most patients need potassium and creatinine checked at baseline, within 1–2 weeks of starting or changing the dose, then periodically (for example, monthly for the first 3 months, then every 3–6 months), with closer monitoring in heart failure or CKD.
Drugs that raise potassium (ACE inhibitors, ARBs, aliskiren, potassium supplements, heparin, trimethoprim), NSAIDs, cyclosporine/tacrolimus, and high-dose TMP-SMX increase risk of hyperkalemia or kidney issues. It can increase digoxin levels and reduce lithium clearance.
Avoid in pregnancy due to antiandrogenic effects that can affect a male fetus. Small amounts of active metabolites appear in breast milk; discuss risks and benefits with your clinician if nursing.
It can cause menstrual irregularities, breast tenderness, and spotting. Because it blocks androgens, it may reduce unwanted hair in women but can cause gynecomastia and sexual side effects in men. Use reliable contraception if of childbearing potential.
Limit high-potassium supplements and salt substitutes. Be cautious with very high-potassium foods (e.g., large amounts of bananas, avocados, coconut water) and stay well hydrated unless otherwise directed.
Yes, many dermatologists use spironolactone off-label for hormonal acne and hirsutism in women; benefits typically appear after 2–3 months. It’s often combined with topical retinoids and requires contraception.
Tablets commonly come in 25 mg, 50 mg, and 100 mg. Doses vary by condition—your clinician will tailor the smallest effective dose based on goals, kidney function, and potassium levels.
If you miss a dose, take it when remembered unless it’s close to the next dose—do not double up. Overdose can cause severe drowsiness, confusion, dehydration, or dangerous hyperkalemia; seek emergency care.
Moderate alcohol can amplify dizziness or low blood pressure. If you drink, limit intake and rise slowly from sitting or lying positions to avoid lightheadedness.
Animal data showed tumor development at high doses; avoid unnecessary use. In humans, long-term use is common for heart failure and hyperaldosteronism with appropriate monitoring of potassium and kidney function.
Keep tablets in a dry place at room temperature, away from moisture and direct light, and out of reach of children and pets.
Do not stop suddenly without guidance—fluid can reaccumulate, blood pressure may rise, and heart failure symptoms can worsen. Your clinician can help taper or transition medications safely.
Both are mineralocorticoid receptor antagonists that improve survival. Eplerenone is more selective, with fewer sex-hormone side effects, but is often costlier and has more CYP3A4 drug interactions; spironolactone is widely available and effective.
Spironolactone generally lowers blood pressure more robustly in resistant hypertension. Eplerenone is a reasonable alternative if spironolactone isn’t tolerated due to gynecomastia or menstrual side effects.
Aldactone has a higher risk of gynecomastia and breast tenderness because it’s less selective and also blocks androgen receptors; eplerenone rarely causes these effects.
Eplerenone is metabolized by CYP3A4 and interacts with strong inhibitors like ketoconazole, clarithromycin, and certain antivirals. Spironolactone has fewer CYP3A4 issues but can raise digoxin levels and interacts with other potassium-raising agents.
Yes. Spironolactone directly blocks the aldosterone receptor, making it more potent for aldosterone-driven conditions. Amiloride works on sodium channels and is less effective for true hyperaldosteronism.
Spironolactone is first-line add-on for resistant hypertension. Amiloride is an alternative if spironolactone isn’t tolerated or causes endocrine side effects, though BP reductions are often smaller.
Both are potassium-sparing diuretics, but triamterene blocks epithelial sodium channels rather than aldosterone receptors. Spironolactone is preferred for hyperaldosteronism and heart failure; triamterene is commonly paired with HCTZ for mild edema or BP.
All can cause hyperkalemia, especially with CKD or ACE inhibitor/ARB use. Risk is broadly similar and driven by kidney function and co-medications; vigilant monitoring is essential with any potassium-sparing agent.
Finerenone is a newer, nonsteroidal MRA approved to reduce kidney and cardiovascular risk in adults with CKD and type 2 diabetes. It has fewer sex-hormone side effects than spironolactone but still carries hyperkalemia risk and is more expensive.
Finerenone has dedicated outcome data and an FDA indication for CKD in type 2 diabetes. Spironolactone can reduce albuminuria but lacks equivalent outcome approvals in this population and has more endocrine side effects.
No. Combining MRAs significantly increases the risk of dangerous hyperkalemia without added clinical benefit; choose one and monitor closely.
Both begin diuresis within hours to days. Eplerenone has a shorter half-life and is often dosed twice daily; spironolactone can usually be given once daily.
Spironolactone. It has robust off-label dermatologic use and evidence for hormonal acne and hirsutism in women. Eplerenone is less studied and less commonly used for these indications.
Generic spironolactone is inexpensive and widely available. Eplerenone is often pricier but available generically in many regions. Finerenone is branded and typically the most expensive.
Yes. Because they don’t block androgen receptors, amiloride and triamterene lack gynecomastia and menstrual side effects, but they do not address aldosterone-driven remodeling and still require potassium monitoring.
Monitoring principles are similar—check potassium and creatinine at baseline and after dose changes, then periodically. Eplerenone may need closer checks with CYP3A4 interactions; finerenone has specific initiation thresholds for eGFR and potassium.